Significance: Cervical cancer is the fourth most common cancer among women globally. Hence, it is crucial to develop a noninvasive and portable optical imaging modality for the early detection of premalignant cervical lesions.
Aim: We present the development and clinical validation of GynoSight v2.0, an indigenously developed multispectral, non-chip-on-tip source, hand-held, portable transvaginal imaging probe, for evaluating tissue health and identifying anomalies, such as those linked to precancerous cervical lesions.
Approach: GynoSight v2.0 houses a 16 LEDs, 5-megapixel camera, and a Raspberry Pi 5 module. A comparative shadowing effect analysis was performed between GynoSight v2.0 and colposcopy by evaluating statistical metrics such as mean pixel intensity (MPI), shadow area percentage (SAP), entropy, and contrast-to-noise ratio. In addition, the relative oxygen saturation maps of the cervical tissue were computed from the multispectral registered image using the proposed discrete Fourier transform-based image registration technique.
Results: The images of ( normal, premalignant, and high-grade squamous intraepithelial lesion) subjects were acquired. A comparative shadowing analysis shows a 50-unit gray level value separation between the colposcope and GynoSight v2.0 images. The pixel values of the colposcope are skewed to the lower pixel values, and the pixel values of GynoSight v2.0 are spread uniformly over 0 to 255 gray-level pixel values. In addition, the statistical analysis showed that MPI, SAP, and entropy are significant metrics for shadowing effect quantification.
Conclusions: The colposcopy images showed more shadowing effects than the GynoSight v2.0 images and hence provide better illumination to aid in better diagnosis.
扫码关注我们
求助内容:
应助结果提醒方式:
